Company: CWAN
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001866368-25-000031
Chunk: 81

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 8
Chunk 81
---
,398 $— 

12

December 31, 2024Adjusted CostUnrealized GainsUnrealized LossesFair ValueCash and Cash EquivalentsShort-Term InvestmentsLong-Term InvestmentsCash$30,431 $— $— $30,431 $30,431 $— $— Level 1 (1):Money market funds145,671 — — 145,671 145,671 — — Level 2 (2):Treasury bills1,462 1 — 1,463 — 1,463 — U.S. government bonds33,567 61 (9)33,619 — 26,566 7,053 U.S. agency securities6,907 — (3)6,904 — — 6,904 Commercial paper10,670 2 — 10,672 1,248 9,424 — Corporate debt securities53,926 112 (17)54,021 — 37,677 16,344 Certificates of deposit3,009 — — 3,009 — 3,009 — Subtotal109,541 176 (29)109,688 1,248 78,139 30,301 Total$285,643 $176 $(29)$285,790 $177,350 $78,139 $30,301 (1) Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities.(2) Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.During each of the nine months ended September 30, 2025 and year ended December 31, 2024, there were no transfers of assets or liabilities between any levels of the fair value hierarchy.

Note 5. Business Combinations

Acquisition of Enfusion Inc.On April 21, 2025 (“Enfusion Acquisition Date”), the Company completed its previously announced acquisition of all outstanding stock of Enfusion, Inc (“Enfusion”), a leader in SaaS solutions for the investment management and hedge fund industry. The following table illustrates